Broadcom vs Cerebras Systems
AVGO and CBRS side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AVGO and CBRS compare
Broadcom is the larger company, worth 60 times as much as Cerebras Systems ($1.6T against $25.9B).
Broadcom pays a dividend yielding 0.80%; Cerebras Systems does not pay one.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AVGO | CBRS |
|---|---|---|
| Size and price | ||
| Market cap | $1.6T | $25.9B |
| Share price | $326.08 | $109.18 |
| Change, 1 year | −15.5% | – |
| Change, 5 years | 483% | – |
| Beta (5Y) | 1.83 | – |
| Employees | 33K | – |
| StockData Score | ||
| Total score | 12 | – |
| Valuation score | 1 | – |
| Growth score | 4 | – |
| Performance score | 0 | – |
| Health score | 4 | – |
| Dividend score | 3 | – |
| Valuation | ||
| P/S | 17.5× | – |
| P/B | – | 2.8× |
| EV/EBITDA | 37.2× | – |
| P/FCF | 39.5× | – |
| FCF yield | 2.5% | – |
| Growth | ||
| Revenue growth (TTM) | 48.7% | – |
| Revenue growth, 5Y average | 21.7% | – |
| EPS growth, 5Y average | 49.8% | – |
| Profitability | ||
| Gross margin | 68.8% | – |
| Operating margin | 48.0% | – |
| FCF margin | 44.2% | – |
| Financial health | ||
| Debt / equity | – | 0.10 |
| Net debt / EBITDA | 0.83 | – |
| Interest coverage | 13.7× | – |
| Current ratio | 2.50 | 5.82 (better) |
| Altman Z-score | 12.15 (better) | 6.91 |
| Dividends and buybacks | ||
| Dividend yield | 0.80% | – |
| Years of dividend growth | 9 | – |
| Dividend growth, 5Y average | 12.7% | – |
| Buyback yield | 0.54% | – |
| Shareholder yield | 1.3% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 77.9% | 37.4% |
| Held by insiders | 0.79% | 28.8% |
| Insider net buying, 12 months | −$1.2B | −$408M (better) |
| Superinvestors holding | 6 (better) | 5 |
| Short interest, % of float | 1.1% | 8.4% |
Go deeper
- AVGO stock overview
- AVGO income statement
- AVGO valuation and score
- CBRS stock overview
- CBRS income statement
- CBRS valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.